GlassScriptPhysician profile
Joseph I Reyes
NPI 1477505808
$3,114.69
in general payments reported to CMS, 2019-2025
16 companies · $239 in 2025
The $239 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $292 · 2020: $169 · 2021: $384 · 2022: $235 · 2023: $568 · 2024: $1,229 · 2025: $239.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,920 · Entertainment: $116.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,919.58 |
| Entertainment | $116.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $950.27 | 2022-2025 | Infuse, Biotrue One Day, Infuse Multifocal |
| Coopervision INC. | $534.82 | 2019-2024 | Myday Contact Lens |
| Glaukos Corporation | $216.59 | 2021-2024 | Istent Trabecular Micro-Bypass System Model Is3 |
| Optos, INC. | $196.47 | 2021-2023 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| Biotissue Holdings INC. | $181.12 | 2024 | |
| Alcon Vision LLC | $173.21 | 2020-2021 | |
| Lombart Brothers, INC. | $171.99 | 2025 | Opd-III |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $136.52 | 2019-2021 | |
| Rxsight INC | $128.57 | 2024 | Light Adjustable Lens (Lal), Rxsight Injector Handpiece, Rxsight Light Delivery Device (Ldd) |
| Sun Pharmaceutical Industries INC. | $121.66 | 2023 | Cequa |
| Amgen INC. | $84.48 | 2024 | Tepezza |
| Konan Medical USA, INC. | $78.81 | 2019 | |
| Optovue, INC. | $65.22 | 2019 | |
| Lkc Technologies, INC. | $31.67 | 2024 | |
| Allergan, INC. | $24.98 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sight Sciences, INC. | $18.31 | 2023 | Tearcare System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Reyes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.